These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 5040221)
41. [A study on slow growing chromogenic (Runyon's group II) mycobacteria]. Pattyn SR; Hermans-Boveroulle MT; van Ermengem J Zentralbl Bakteriol Orig; 1968; 207(4):509-16. PubMed ID: 5742981 [No Abstract] [Full Text] [Related]
42. [Experiments for isolating and cultivating mycobacteria, living in the soil. (Methodological article)]. Szelényi F; Berencsi G Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1970; 125(1):54-70. PubMed ID: 4925948 [No Abstract] [Full Text] [Related]
43. The production of an antibiotic substance by Mycobacterium album subsp hyalinum Krasilnikov, 1941. Musial M Acta Microbiol Pol B; 1972; 4(2):61-73. PubMed ID: 4601951 [No Abstract] [Full Text] [Related]
44. Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium capable of forming a black product from p-aminosalicylate and salicylate. Tsukamura M; Mizuno S J Gen Microbiol; 1971 Oct; 68(2):129-34. PubMed ID: 5136244 [No Abstract] [Full Text] [Related]
45. Comparative investigation in vitro of the sensibility of atypical mycobacteria to cycloserine and to other antibacterial substances. Gernez-Rieux C; Devulder B Scand J Respir Dis Suppl; 1970; 71():22-34. PubMed ID: 5271991 [No Abstract] [Full Text] [Related]
46. Microbiology and classification of mycobacteria. Eisenstadt J; Hall GS Clin Dermatol; 1995; 13(3):197-206. PubMed ID: 8521362 [No Abstract] [Full Text] [Related]
47. [Differentiation of mycobacteria in agar column according to Lebek (author's transl)]. Cesk Epidemiol Mikrobiol Imunol; 1976 May; 25(2):82-7. PubMed ID: 132296 [No Abstract] [Full Text] [Related]
48. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)]. Casal M; Rodriguez F Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191 [TBL] [Abstract][Full Text] [Related]
49. Studies on acyclic pyrimidines as inhibitors of mycobacteria. Srivastav NC; Manning T; Kunimoto DY; Kumar R Bioorg Med Chem; 2007 Mar; 15(5):2045-53. PubMed ID: 17218105 [TBL] [Abstract][Full Text] [Related]
50. [Classification of the so-called atypical mycobacteria]. Janowiec M Gruzlica; 1968 Oct; 36(11):1097-101. PubMed ID: 5710698 [No Abstract] [Full Text] [Related]
51. The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria. Riska PF; Jacobs WR Methods Mol Biol; 1998; 101():431-55. PubMed ID: 9921495 [No Abstract] [Full Text] [Related]
52. Cholesterol is accumulated by mycobacteria but its degradation is limited to non-pathogenic fast-growing mycobacteria. Av-Gay Y; Sobouti R Can J Microbiol; 2000 Sep; 46(9):826-31. PubMed ID: 11006843 [TBL] [Abstract][Full Text] [Related]
53. Numerical classification of atypical Mycobacteria. Tsukamura M; Mizuno S; Tsukamura S Jpn J Microbiol; 1967 Dec; 11(4):233-41. PubMed ID: 5301575 [No Abstract] [Full Text] [Related]
55. [The effect of acetone upon the viability and the dehydrogenase enzyme of mycobacteria]. Weiszfeiler GJ; Czanik P; Bátkai L Zentralbl Bakteriol Orig; 1968; 207(4):517-21. PubMed ID: 5742982 [No Abstract] [Full Text] [Related]
56. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA. Dutta NK; Mazumdar K; Dastidar SG; Chakrabarty AN; Shirataki Y; Motohashi N In Vivo; 2005; 19(3):539-45. PubMed ID: 15875773 [TBL] [Abstract][Full Text] [Related]
57. [Serologic examination of atypical mycobacteria with the agglutination method]. Anz W; Meissner G; Röder U Zentralbl Bakteriol Orig; 1969; 211(4):530-50. PubMed ID: 5394171 [No Abstract] [Full Text] [Related]